METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
- 专利权人:
- Institut Curie;INSERM (Institut National de la Sante et de la Recherche)
- 发明人:
- Marc-Henri Stern,Elodie Manie,Tatiana Popova
- 申请号：
- US14402254
- 公开号：
- US20150140122A1
- 申请日:
- 2013.06.06
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- The invention relates to methods for detecting inactivation of the DNA Homologous Recombination pathway in a patient, and in particular for detecting BRCA1 inactivation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
- METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
- RECOMBINANT HUMAN CLN2 PROTEIN AND METHODS OF ITS PRODUCTION AND USE
- VACCIN CONTRE LA ROUGEOLE RECOMBINANT EXPRIMANT HTERT
- antigen binding protein, nucleic acid molecule, expression vector, recombinant host cell, method for producing an antigen binding protein, pharmaceutical composition, and methods for treating a patient, and for increasing muscle mass, increasing muscle strength, and / or improve muscle function in a patient
